Insider transaction 📈 Stocks 🌍 United States

ICU Medical CFO Brian Bonnell Sells 9,307 Shares in Pre-Scheduled Trade

CFO Brian Bonnell offloaded 9,307 shares of ICU Medical under a pre-scheduled plan, maintaining a significant $10.8 million stake in the medical technology firm.

📅 September 17, 2026 🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: ICUI → 1/10 (60% confidence).

📊 Affected Assets (1)

ICUI

Neutral 🤖 60%

📅 Short-term 🌍 US · Explicit

CFO Brian Bonnell sold 9,307 shares under a pre-scheduled Rule 10b5-1 plan, retaining over 62,000 shares, which represents a planned and non-opportunistic insider transaction with minimal market impact.

🎯 Key Takeaways

The sale of 9,307 shares was executed via a pre-scheduled Rule 10b5-1 plan, minimizing concerns regarding insider sentiment.
Bonnell retains 62,443 shares, valued at $10.8 million, maintaining significant skin in the game.
ICU Medical shares have outperformed the S&P 500 over the past year, with analysts maintaining a largely bullish outlook.

📝 Executive Summary

ICU Medical CFO Brian Bonnell sold 9,307 shares of the company on August 31, 2026, as part of a pre-established Rule 10b5-1 trading plan. The transaction, valued at approximately $1.6 million, leaves Bonnell with a remaining stake of 62,443 shares, signaling continued alignment with the firm's long-term performance.

❓ FAQ

Why did the CFO sell shares of ICU Medical?

The sale was conducted under a pre-determined Rule 10b5-1 trading plan established in June 2026, which is a standard mechanism used by insiders to sell stock without triggering concerns about non-public information.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article